🏛️ Verified NIH Record • Updated 2026-07-08
Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device (NCT07701161)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Neurogen Biomarking LLC
🩺 Plain-English Summary (8th-Grade Level)
This study compares p-tau217 concentrations in blood collected via the Tasso device versus standard venipuncture in subjects with and without Alzheimer's disease, including a subset with confirmed amyloid pathology.
Who can join: Review the eligibility criteria below.
Location: Insigth Hospital and Medical Center Chicago — Chicago, Illinois
Age range: 40 Years to 90 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (5 Sites)
- Insigth Hospital and Medical Center Chicago — Chicago, Illinois
- Insight Hospital and Medical Center Dearborn — Dearborn, Michigan
- Insight Institute of Neurology and Neurosurgery — Flint, Michigan
- Memorial Healthcare Hospital — Owosso, Michigan
- Wake Forest Baptist Medical Center — Winston-Salem, North Carolina
📞 Contact the Study Coordinator
Phone: (810) 941-0076
Email: ansam@neurogenbiomarking.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Alzheimer s Disease
- Ultrasonic Debris Clearance to Promote Brain Resilience — Stanford, California
- Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia — Toronto, Ontario
- PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) — Bethesda, Maryland
- Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition — Baton Rouge, Louisiana
- Crownlands Observing Progression With Neurons Study — Germantown, Maryland
Explore by condition: All Alzheimer s Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.